Chemotherapy Enhances CD8+ T Cell-mediated Antitumor Immunity Induced by Vaccination With Vaccinia Virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapy Enhances CD8+ T Cell-mediated Antitumor Immunity Induced by Vaccination With Vaccinia Virus

Published:2007-08 Issue:8 Volume:15 Page:1558-1563
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Song Chung Kil,Han Hee Dong,Noh Kyung Hee,Kang Tae Heung,Park Yong Sung,Kim Jin Hee,Park Eun Suk,Shin Byung Cheol,Kim Tae Woo

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference23 articles.

1. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination;Kang;Cancer Res,2007

2. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies;Kim;J Immunol,2003

3. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia colilac repressor;Zhang;J Virol,1991

4. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein;Ji;Int J Cancer,1998

5. Low-dose vaccinia virus-mediated cytokine gene therapy of glioma;Chen;J Immunother,2001

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review;Cell Death & Disease;2024-04-09

2. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy;Frontiers in Immunology;2024-01-29

3. Tannins in cancer prevention and therapy;British Journal of Pharmacology;2023-10-03

4. A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer;International Journal of Gynecologic Cancer;2023-09

5. Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer;JAMA Oncology;2023-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3